Literature DB >> 27234491

Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy.

Yingjie Xu1, Quanbin Zhang2, Dali Luo3, Jing Wang4, Delin Duan5.   

Abstract

Diabetic nephropathy (DN) is a serious microvascular complication that can lead to chronic and end-stage renal failure. It is understood that inflammation is associated with the onset and process of DN. Low molecular weight fucoidan (LMWF) isolated from Saccharina japonica has anti-inflammatory properties. Therefore, this study aimed to explore the mechanism of LMWF in DN model induced by streptozotocin. The biochemical indices levels showed LMWF reduced the DN diagnostic indices to protect renal function. The HE stained sections exhibited LMWF protected normal morphological structures and reduced inflammatory cell infiltration in the kidneys of DN rats. Furthermore, the levels of P-selectin and selectin-dependent inflammatory cytokines resulting from LMWF were obviously decreased at both the transcriptional and protein levels. Thus, our results found that LMWF protected the renal function in DN rats and alleviated inflammation through the modulation of P-selectin and inflammatory cytokines. LMWF may have therapeutic potential against DN.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Fucoidan; P-selectin

Mesh:

Substances:

Year:  2016        PMID: 27234491     DOI: 10.1016/j.ijbiomac.2016.05.081

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  8 in total

Review 1.  The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.

Authors:  Brooke L Farrugia; Megan S Lord; James Melrose; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

2.  Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells.

Authors:  In-Hye Kim; Mi-Jin Kwon; Taek-Jeong Nam
Journal:  Mol Med Rep       Date:  2017-04-27       Impact factor: 2.952

3.  Low molecular weight fucoidan attenuates experimental abdominal aortic aneurysm through interfering the leukocyte-endothelial cells interaction.

Authors:  Min Zhou; Yong Ding; Liang Cai; Yonggang Wang; Changpo Lin; Zhenyu Shi
Journal:  Mol Med Rep       Date:  2018-03-16       Impact factor: 2.952

4.  Genome-wide analysis of the Saccharina japonica sulfotransferase genes and their transcriptional profiles during whole developmental periods and under abiotic stresses.

Authors:  Chang Lu; Zhanru Shao; Pengyan Zhang; Delin Duan
Journal:  BMC Plant Biol       Date:  2020-06-11       Impact factor: 4.215

Review 5.  Algal Polysaccharides as Therapeutic Agents for Atherosclerosis.

Authors:  Nikita P Patil; Victoria Le; Andrew D Sligar; Lei Mei; Daniel Chavarria; Emily Y Yang; Aaron B Baker
Journal:  Front Cardiovasc Med       Date:  2018-10-26

6.  Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism.

Authors:  Yan Wang; Yanlei Sun; Fengli Shao; Bo Zhang; Zhen Wang; Xinpeng Li
Journal:  J Diabetes Res       Date:  2021-11-24       Impact factor: 4.011

7.  Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology.

Authors:  Meilan Xue; Hui Liang; Xinqiang Ji; Ying Liu; Yinlin Ge; Lin Hou; Ting Sun
Journal:  Nutr Metab (Lond)       Date:  2019-12-16       Impact factor: 4.169

Review 8.  Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances.

Authors:  Qi Cao; Jiarui Zhao; Maochen Xing; Han Xiao; Qian Zhang; Hao Liang; Aiguo Ji; Shuliang Song
Journal:  Mar Drugs       Date:  2020-08-25       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.